Now Available: Biospecimen Evidence-Based Practices
BBRB is pleased to make available the first in what will be an expanding collection of procedural guidelines developed using, and annotated with, evidence from primary research publications in the field of human Biospecimen Science. Read More…
Survey on Financial Sustainability on Biobanking
You are invited to participate in a survey investigating the financial challenges facing biobanks today. The data collected in this survey will be used to develop published guidance that will be publicly available to the research community and the larger medical community. For more information, see the
full news release.
Genotype Tissue Expression Project (GTEx) Biospecimens Access Policy now available
We are pleased to announce that the Genotype-Tissue Expression Project (GTEx) Biospecimens Access Policy is now live. Read More…
Welcome to the Biorepositories and Biospecimen Research Branch!
The Biorepositories and Biospecimen Research Branch (BBRB) of the Cancer Diagnosis Program (CDP), is leading a national initiative to systematically address and resolve one of the most difficult problems that will drive 21st century cancer research: the limited availability of carefully collected and controlled, high-quality human biospecimens annotated with essential clinical data and properly consented for broad investigational use. BBRB is pursuing its mission to facilitate cancer and biomedical research by improving the quality and consistency of human biospecimens and by developing biorepository standards and facilitating Biospecimen Science studies that form the basis of evidence-based practices to guide clinical cancer research and other biomedical studies which utilize biospecimens.